Literature DB >> 18997886

Heterotopic heart transplantation in mice.

Fengchun Liu1, Sang Mo Kang.   

Abstract

The mouse heterotopic heart transplantation has been used widely since it was introduced by Drs. Corry and Russell in 1973. It is particularly valuable for studying rejection and immune response now that newer transgenic and gene knockout mice are available, and a large number of immunologic reagents have been developed. The heart transplant model is less stringent than the skin transplant models, although technically more challenging. We have developed a modified technique and have completed over 1000 successful cases of heterotopic heart transplantation in mice. When making anastomosis of the ascending aorta and abdominal aorta, two stay sutures are placed at the proximal and distal apexes of recipient abdominal aorta with the donor s ascending aorta, then using 11-0 suture for anastomosis on both side of aorta with continuing sutures. The stay sutures make the anastomosis easier and 11-0 is an ideal suture size to avoid bleeding and thrombosis.When making anastomosis of pulmonary artery and inferior vena cava, two stay sutures are made at the proximal apex and distal apex of the recipient s inferior vena cava with the donor s pulmonary artery. The left wall of the inferior vena cava and donor s pulmonary artery is closed with continuing sutures in the inside of the inferior vena cava after, one knot with the proximal apex stay suture the right wall of the inferior vena cava and the donor s pulmonary artery are closed with continuing sutures outside the inferior vena cave with 10-0 sutures. This method is easier to perform because anastomosis is made just on the one side of the inferior vena cava and 10-0 sutures is the right size to avoid bleeding and thrombosis. In this article, we provide details of the technique to supplement the video.

Entities:  

Mesh:

Year:  2007        PMID: 18997886      PMCID: PMC2557111          DOI: 10.3791/238

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  1 in total

1.  Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection.

Authors:  R J Corry; H J Winn; P S Russell
Journal:  Transplantation       Date:  1973-10       Impact factor: 4.939

  1 in total
  8 in total

1.  A simplified two-stitch sleeve technique for arterial anastomosis of cervical heterotopic cardiac transplantation in mice.

Authors:  Jing Fang; Long He; Shi-Qiang Wang; Ming-Jia Ma; Hong-Yun Liu; Xue-Hai Zhu; Ping Zhu; Xiang Wei; Cong-Yi Wang
Journal:  Am J Transl Res       Date:  2013-08-15       Impact factor: 4.060

2.  Functional Characterization of Regulatory Macrophages That Inhibit Graft-reactive Immunity.

Authors:  Jordi Ochando; Patricia Conde
Journal:  J Vis Exp       Date:  2017-06-07       Impact factor: 1.355

3.  A modified method for heterotopic mouse heart transplantion.

Authors:  Chuanmin Wang; Zane Wang; Richard Allen; G Alex Bishop; Alexandra F Sharland
Journal:  J Vis Exp       Date:  2014-06-23       Impact factor: 1.355

4.  Heterotopic Cervical Heart Transplantation in Mice.

Authors:  Thomas Ratschiller; Marcus-André Deutsch; Julia Calzada-Wack; Frauke Neff; Christiane Roesch; Ralf Guenzinger; Ruediger Lange; Markus Krane
Journal:  J Vis Exp       Date:  2015-08-25       Impact factor: 1.355

5.  Single Donor Infusion of S-Nitroso-Human-Serum-Albumin Attenuates Cardiac Isograft Fibrosis and Preserves Myocardial Micro-RNA-126-3p in a Murine Heterotopic Heart Transplant Model.

Authors:  Anne-Kristin Schaefer; Attila Kiss; André Oszwald; Felix Nagel; Eylem Acar; Arezu Aliabadi-Zuckermann; Matthias Hackl; Andreas Zuckermann; Renate Kain; Andrzej Jakubowski; Peter Ferdinandy; Seth Hallström; Bruno K Podesser
Journal:  Transpl Int       Date:  2022-04-13       Impact factor: 3.842

6.  Murine heterotopic heart transplant technique.

Authors:  Robert J Plenter; Todd J Grazia
Journal:  J Vis Exp       Date:  2014-07-08       Impact factor: 1.355

7.  Rap1 deficiency-provoked paracrine dysfunction impairs immunosuppressive potency of mesenchymal stem cells in allograft rejection of heart transplantation.

Authors:  Yue Ding; Xiaoting Liang; Yuelin Zhang; Li Yi; Ho Cheung Shum; Qiulan Chen; Barbara P Chan; Huimin Fan; Zhongmin Liu; Vinay Tergaonkar; Zhongquan Qi; Hung-Fat Tse; Qizhou Lian
Journal:  Cell Death Dis       Date:  2018-03-07       Impact factor: 8.469

8.  Heparan sulfate is a plasma biomarker of acute cellular allograft rejection.

Authors:  Andrew S Barbas; Liwen Lin; MacKenzie McRae; Andrea L MacDonald; Tracy Truong; Yiping Yang; Todd V Brennan
Journal:  PLoS One       Date:  2018-08-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.